Dr Peter Pockney

Dr Peter Pockney

Senior Lecturer

School of Medicine and Public Health (Medicine)

Career Summary

Biography

Dr Peter Pockney has been the Senior Lecturer in Surgery at the University of Newcastle since 2011. In this role, he combines an active teaching and research commitment to the School of Medicine and Public Health with clinical practice as a specialist colorectal, general and trauma surgeon at the John Hunter Hospital, Newcastle.

Peter completed undergraduate medicine at University College London in 1996, graduating with Distinction in Surgery and Merit in Medicine.  He did basic clinical training at University College London, Southampton University Hospitals and Cambridge University Hospitals before completing his Doctorate of Medicine in 2004 at Southampton University under the Supervision of Professor John Primrose. This research was in the field of surgical randomised clinical trials, which remained the main focus of his research activity until 2016.

After finishing research training and his DM, Peter completed higher surgical training in 2007, specialising in General and Colorectal surgery. A subspecialty fellowship in Newcastle, NSW in 2008 was followed by 2 years working as a Consultant Surgeon in London.

Peter returned to Newcastle as the Senior Lecturer in Surgery in 2011.  He has the role of course coordinator for surgery in the BMed, which includes responsibility for course and assessment design, and approximately 10 hours a week contact time teaching with the students.

His research activity has included being the Chief Investigator and contributor to 5 randomised clinical trials aimed at improving outcomes after major colorectal surgery, and three prospective studies of biomarkers as indicators of adverse events in surgery. He has also led a major project in service redesign to improve access to colonoscopy for people at high risk of bowel cancer, and a further study that improved cost effectiveness and efficiency in the operating theatre during common surgical procedures.

In 2016 he led an initiative that brought together the Hunter New England Local Health District and the University of Newcastle to support 4 Junior Clinical Fellows in Surgical Research and Teaching.  These Fellows are funded through part-time work for the hospital to teach undergraduate students and to conduct high quality research.  The projects being undertaken include examining the role of circulating cell free tumour DNA as a biomarker for colorectal cancer, the role of Neutrophil Extracellular Traps in colorectal cancer metastases, neurotrophic growth factors in prostate cancer, a randomised clinical trial of prehabilitation in major upper gastrointestinal surgery, and a multicentre audit of emergency laparotomy operations.

This program is being extended in 2018, with 12 positions being offered across General and Colorectal Surgery, Neurosurgery, Cardiothoracic surgery and Trauma surgery. Other projects being undertaken under his supervision include examining the role of the colonic microbiome in anastomotic leaks, the utility of a biomarker in diagnosis of acute appendicitis, and the role of variations in the genome of CD36 in the phenotype of Familial Adenomatous Polyposis.

Membership

Royal Australasian College of Surgeons, Section of Academic Surgeons

Colorectal Surgical Society of Australia and New Zealand


Qualifications

  • Doctor of Medicine, University of Southampton - UK
  • Bachelor of Science (Honours)(Geography), University of Exeter - UK
  • Bachelor of Medicine, Bachelor of Surgery, University of London
  • Post Graduate Cert-Completion of Train(Gen Surgery, Post Graduate Medical Educ & Training Board - UK

Keywords

  • Clinical Trials
  • Colorectal Cancer
  • Colorectal Cancer Screening
  • Colorectal Surgery
  • FAP
  • Neutrophil Extracellular Traps

Fields of Research

Code Description Percentage
080799 Library and Information Studies not elsewhere classified 30
110399 Clinical Sciences not elsewhere classified 35
111799 Public Health and Health Services not elsewhere classified 35

Professional Experience

UON Appointment

Title Organisation / Department
Senior Lecturer University of Newcastle
School of Medicine and Public Health
Australia
Senior Lecturer Priority Research Centre (PRC) for Healthy Lungs | The University of Newcastle
School of Medicine and Public Health
Australia
Senior Lecturer University of Newcastle
School of Medicine and Public Health
Australia

Professional appointment

Dates Title Organisation / Department
11/01/2011 - 21/07/2028 Consultant Surgeon

Consultant Colorectal and General Surgeon.

John Hunter Hospital, Newcastle
Colorectal Surgery
Australia
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (1 outputs)

Year Citation Altmetrics Link
2019 Gould T, Jamaluddin M, Petit J, King SJ, Nixon B, Scott R, et al., 'Finding Needles in Haystacks: The Use of Quantitative Proteomics for the Early Detection of Colorectal Cancer', Advances in the Molecular Understanding of Colorectal Cancer, IntechOpen, Switzerland 1-32 (2019) [B1]
DOI 10.5772/intechopen.80942
Co-authors Rodney Scott, Matt Dun, Brett Nixon, Muhammad Jamaluddin

Journal article (31 outputs)

Year Citation Altmetrics Link
2019 Clarke L, Pockney P, Gillies D, Foster R, Gani J, 'Direct access colonoscopy service for bowel cancer screening produces a positive financial benefit for patients and local health districts.', Internal medicine journal, 49 729-733 (2019)
DOI 10.1111/imj.14149
Co-authors Jonathan Gani
2019 Petit J, Carroll G, Gould T, Pockney P, Dun M, Scott RJ, 'Cell-free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review', Journal of Surgical Research, 236 184-197 (2019)

© 2018 Elsevier Inc. Background: Circulating tumour DNA (ctDNA) has emerged as an excellent candidate for the future of liquid biopsies for many cancers. There has been growing in... [more]

© 2018 Elsevier Inc. Background: Circulating tumour DNA (ctDNA) has emerged as an excellent candidate for the future of liquid biopsies for many cancers. There has been growing interest in blood-based liquid biopsy because of the potential of ctDNA to produce a noninvasive test that can be used for: the diagnosis of colorectal cancer, monitoring therapy response, and providing information on overall prognosis. The aim of this review was to collate and explore the current evidence regarding ctDNA as a screening tool for colorectal cancer (CRC). Methods: A systematic review of published articles in English over the past 20 y was performed using Medline, Embase, and Cochrane databases on May 23, 2017. After a full-text review, a total of 69 studies were included. Two assessment tools were used to review and compare the methodological quality of these studies. Results: Among the 69 studies included, 17 studies reviewed total cfDNA, whereas six studies looked at the DNA integrity index and 15 focused on ctDNA. There were a total of 40 studies that reviewed methylated cfDNA with 19 of these focussing specifically on SEPT9. Conclusions: The results of this review indicate that methylated epigenetic ctDNA markers are perhaps the most promising candidates for a blood-based CRC-screening modality using cell-free (cf) DNA. Methylated cfDNA appears to be less specific for CRC compared to ctDNA; however, they have demonstrated good sensitivity for early-stage CRC. Further research is required to determine which methylated cfDNA markers are the most accurate when applied to large cohorts of patients. In addition, reliable comparison of results across multiple studies would benefit from standardization of methodology for DNA extraction and PCR techniques in the future.

DOI 10.1016/j.jss.2018.11.029
Citations Scopus - 3Web of Science - 1
Co-authors Rodney Scott, Matt Dun
2018 Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R, 'Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial', Diseases of the Colon and Rectum, 61 99-106 (2018) [C1]

© 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolyti... [more]

© 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss in a variety of clinical conditions. Information regarding the use of tranexamic acid in treating lower GI hemorrhage is lacking. OBJECTIVE: The aim of this trial was to determine the clinical efficacy of tranexamic acid when used for lower GI hemorrhage. DESIGN: This was a prospective, double-blind, placebo-controlled, randomized clinical trial. SETTINGS: The study was conducted at a tertiary referral university hospital in Australia. PATIENTS: Consecutive patients aged >18 years with lower GI hemorrhage requiring hospital admission from November 2011 to January 2014 were screened for trial eligibility (N = 265). INTERVENTIONS: A total of 100 patients were recruited after exclusions and were randomly assigned 1:1 to either tranexamic acid or placebo. MAIN OUTCOME MEASURES: The primary outcome was blood loss as determined by reduction in hemoglobin levels. The secondary outcomes were transfusion rates, transfusion volume, intervention rates for bleeding, length of hospital stay, readmission, and complication rates. RESULTS: There was no difference between groups with respect to hemoglobin drop (11 g/L of tranexamic acid vs 13 g/L of placebo; p = 0.9445). There was no difference with respect to transfusion rates (14/49 tranexamic acid vs 16/47 placebo; p = 0.661), mean transfusion volume (1.27 vs 1.93 units; p = 0.355), intervention rates (7/49 vs 13/47; p = 0.134), length of hospital stay (4.67 vs 4.74 d; p = 0.934), readmission, or complication rates. No complications occurred as a direct result of tranexamic acid use. LIMITATIONS: A larger multicenter trial may be required to determine whether there are more subtle advantages with tranexamic acid use in some of the secondary outcomes. CONCLUSIONS: Tranexamic acid does not appear to decrease blood loss or improve clinical outcomes in patients presenting with lower GI hemorrhage in the context of this trial. see Video Abstract at http://links.lww.com/DCR/A453.

DOI 10.1097/DCR.0000000000000943
Citations Scopus - 3Web of Science - 2
Co-authors Stephen Smith
2018 Almazi JG, Pockney P, Gedye C, Smith ND, Hondermarck H, Verrills NM, Dun MD, 'Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.', Proteomics. Clinical applications, 12 e1700121 (2018) [C1]
DOI 10.1002/prca.201700121
Co-authors Hubert Hondermarck, Nikki Verrills, Matt Dun, Craig Gedye
2018 Clarke L, Pockney P, Gillies D, Foster R, Gani J, 'Time to colonoscopy for patients accessing the Direct Access Colonoscopy Service compared to the normal service in Newcastle, Australia.', Internal medicine journal, (2018)
DOI 10.1111/imj.14157
Co-authors Jonathan Gani
2018 Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E, et al., 'Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard.', ANZ journal of surgery, 88 440-444 (2018) [C1]
DOI 10.1111/ans.13937
Citations Scopus - 5Web of Science - 3
Co-authors Stephen Smith, John Attia, Liz Holliday
2018 March B, Leigh L, Brussius-Coelho M, Holmes M, Pockney P, Gani J, 'Can CRP velocity in right iliac fossa pain identify patients for intervention? A prospective observational cohort study', Surgeon, (2018)

© 2018 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland Introduction: Previous studies have shown single CRP meas... [more]

© 2018 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland Introduction: Previous studies have shown single CRP measurements at time of presentation to have limited predictive benefit for appendicitis. Our objective was to determine the diagnostic utility of serial CRP measurements (to determine CRP velocity [CRPv]) in patients with right iliac fossa (RIF) pain. Methods: A single-centre prospective observational study was conducted on adult patients admitted with RIF pain. CRP was measured on admission, at midnight, and the following morning. Appendicitis was diagnosed on histopathology, or diagnostic imaging in non-operatively managed patients. Therapeutic interventions included all appropriate operative procedures and effective non-operative treatment with antibiotics. Logistic regression was used to generate predictors of therapeutic intervention, and then used to create a new risk score incorporating CRPv. Results: 98 of 112 (87.5%) participants had complete CRP data. 58 patients met the criteria for appendicitis (59.2%). Most patients presented with intermediate Modified Alvarado Scores (MAS) 5¿6 (40.8%) or Appendicitis Inflammatory Response Scores (AIRS) 5¿8 (49%). Our risk score had an AUROC of 0.88 (95% CI 0.81¿0.96) in predicting therapeutic intervention. This score was superior to MAS, AIRS, and single admission biomarker measurements. Patients with an increasing CRPv had 14 times the odds (OR 14.07, 95% CI 0.63¿315.2) of complicated appendicitis, and no cases of complicated appendicitis were observed in patients with a flat CRPv. Conclusions: CRP velocity is superior to single CRP at predicting intervention. Our v-Score shows promise as a decision making-aide by predicting the need for surgical intervention in RIF pain. A flat CRPv identifies a group of patients with a very low risk of complicated appendicitis.

DOI 10.1016/j.surge.2018.08.007
Citations Scopus - 1
Co-authors Jonathan Gani
2018 Holmes R, Smith SR, Carroll R, Holz P, Mehrotra R, Pockney P, 'Randomized clinical trial to assess the ideal mode of delivery for local anaesthetic abdominal wall blocks.', ANZ journal of surgery, 88 786-791 (2018) [C1]
DOI 10.1111/ans.14317
Citations Scopus - 2Web of Science - 3
Co-authors Stephen Smith
2018 Smith SR, Holmes R, Pockney P, Holz P, Carroll R, Mehrotra R, 'Response to Re: Randomized clinical trial to assess the ideal mode of delivery for local anaesthetic abdominal wall blocks', ANZ JOURNAL OF SURGERY, 88 805-806 (2018)
DOI 10.1111/ans.14766
Citations Scopus - 1
Co-authors Stephen Smith
2018 Holmes M, Connor T, Oldmeadow C, Pockney PG, Scott RJ, Talseth-Palmer BA, 'CD36-a plausible modifier of disease phenotype in familial adenomatous polyposis', HEREDITARY CANCER IN CLINICAL PRACTICE, 16 (2018) [C1]
DOI 10.1186/s13053-018-0096-y
Citations Scopus - 1Web of Science - 1
Co-authors Christopher Oldmeadow, Bente Talseth-Palmer, Rodney Scott
2017 Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al., 'Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases', Annals of Surgery, 266 111-117 (2017) [C1]

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transana... [more]

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transanal Total Mesorectal Excision (taTME) registry for benign and malignant rectal pathology. Background: TaTME is the latest minimally invasive transanal technique pioneered to facilitate difficult pelvic dissections. Outcomes have been published from small cohorts, but larger series can further assess the safety and efficacy of taTME in the wider surgical population. Methods: Data were analyzed from 66 registered units in 23 countries. The primary endpoint was "good-quality TME surgery." Secondary endpoints were short-term adverse events. Univariate and multivariate regression analyses were used to identify independent predictors of poor specimen outcome. Results: A total of 720 consecutively registered cases were analyzed comprising 634 patients with rectal cancer and 86 with benign pathology. Approximately, 67% were males with mean BMI 26.5 kg/m 2. Abdominal or perineal conversion was 6.3% and 2.8%, respectively. Intact TME specimens were achieved in 85%, with minor defects in 11% and major defects in 4%. R1 resection rate was 2.7%. Postoperative mortality and morbidity were 0.5% and 32.6% respectively. Risk factors for poor specimen outcome (suboptimal TME specimen, perforation, and/or R1 resection) on multivariate analysis were positive CRM on staging MRI, low rectal tumor <2 cm from anorectal junction, and laparoscopic transabdominal posterior dissection to <4 cm from anal verge. Conclusions: TaTME appears to be an oncologically safe and effective technique for distal mesorectal dissection with acceptable short-term patient outcomes and good specimen quality. Ongoing structured training and the upcoming randomized controlled trials are needed to assess the technique further.

DOI 10.1097/SLA.0000000000001948
Citations Scopus - 103Web of Science - 106
2017 Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, et al., 'Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing', MOLECULAR ONCOLOGY, 11 208-219 (2017) [C1]
DOI 10.1002/1878-0261.12023
Citations Scopus - 34Web of Science - 35
Co-authors Stephen Smith, Rodney Scott
2017 Zala A, Bollipo SJ, Pockney P, Foster R, 'Endoscopic Removal of a Large Kitchen Knife', GASTROINTESTINAL ENDOSCOPY, 85 AB126-AB126 (2017)
DOI 10.1016/j.gie.2017.03.210
2017 'Abstract Journal General Surgery', ANZ Journal of Surgery, 87 41-60 (2017)
DOI 10.1111/ans.13993
2015 Smith S, Pockney P, Attia J, 'Corrigendum: A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', Diseases of the colon and rectum, 58 e416 (2015) [O1]
DOI 10.1097/dcr.0000000000000407
Co-authors Stephen Smith, John Attia
2015 Smith SR, Draganic B, Pockney P, Holz P, Holmes R, Mcmanus B, Carroll R, 'Transversus abdominis plane blockade in laparoscopic colorectal surgery: a double-blind randomized clinical trial', INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30 1237-1245 (2015) [C1]
DOI 10.1007/s00384-015-2286-7
Citations Scopus - 16Web of Science - 17
Co-authors Stephen Smith
2015 'Abstract Journal for General Surgery', ANZ Journal of Surgery, 85 43-59 (2015)
DOI 10.1111/ans.13084
2015 'Abstract Journal for Pain Medicine (RACS)', ANZ Journal of Surgery, 85 93-94 (2015)
DOI 10.1111/ans.13093
2014 Ho YM, Smith SR, Pockney P, Lim P, Attia J, 'A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', DISEASES OF THE COLON & RECTUM, 57 115-126 (2014) [C1]
DOI 10.1097/DCR.0b013e3182a665be
Citations Scopus - 28Web of Science - 25
Co-authors John Attia, Stephen Smith
2014 'Colorectal Surgery Program Abstracts', ANZ Journal of Surgery, 84 30-52 (2014)
DOI 10.1111/ans.12609
2014 'The Six Best Abstracts', Colorectal Disease, 16 1-2 (2014)
DOI 10.1111/codi.12638
2010 Reid K, Pockney PG, Pollitt T, Draganic B, Smith SR, 'Randomized clinical trial of short-term outcomes following purse-string versus conventional closure of ileostomy wounds', British Journal of Surgery, 97 1511-1517 (2010) [C1]
DOI 10.1002/bjs.7151
Citations Scopus - 47Web of Science - 41
Co-authors Stephen Smith
2010 Reid K, Pockney P, Draganic B, Smith S, 'Barrier wound protection decreases surgical site infection in open elective colorectal surgery: A randomized clinical trial', Diseases of the Colon & Rectum, 53 1374-1380 (2010) [C1]
DOI 10.1007/DCR.0b013e3181ed3f7e
Citations Scopus - 57Web of Science - 50
Co-authors Stephen Smith
2009 Pockney PG, Primrose J, George S, Jayatilleke N, Leppard B, Smith H, et al., 'Recognition of skin malignancy by general practitioners: Observational study using data from a population-based randomised controlled trial', British Journal of Cancer, 100 24-27 (2009) [C1]
DOI 10.1038/sj.bjc.6604810
Citations Scopus - 15Web of Science - 15
2008 George S, Pockney PG, Primrose J, Smith H, Little P, Kinley H, et al., 'A prospective randomised comparison of minor surgery in primary and secondary care. The MISTIC trial', Health Technology Assessment, 12 1-30 (2008) [C1]
DOI 10.3310/hta12230
Citations Scopus - 29
2008 George S, Pockney P, Primrose J, Smith H, Little P, Kinley H, et al., 'A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial', HEALTH TECHNOLOGY ASSESSMENT, 12 III-+ (2008)
Citations Web of Science - 20
2004 Pockney P, George S, Primrose J, Smith H, Kinley H, Little P, et al., 'Impact of the introduction of fee for service payments on types of minor surgical procedures undertaken by general practitioners: observational study', JOURNAL OF PUBLIC HEALTH, 26 264-267 (2004)
DOI 10.1093/pubmed/fdh152
Citations Scopus - 3Web of Science - 4
2002 Smith GB, Nolan J, King A, Pockney P, Nielsen M, Coombes M, et al., 'Medical emergency teams and cardiac arrests in hospital [3] (multiple letters)', British Medical Journal, 324 1215-1216 (2002)
Citations Scopus - 4
2002 King A, Pockney P, Nielsen M, Coombes M, Bailey I, Clancy M, 'Medical emergency teams and cardiac arrests in hospital. Bottom up approach works too.', BMJ (Clinical research ed.), 324 (2002)
Citations Scopus - 1
2002 Smith GB, Nolan J, 'Medical emergency teams and cardiac arrests in hospital - Results may have been due to education of ward staff', BRITISH MEDICAL JOURNAL, 324 1215-1215 (2002)
Citations Scopus - 9Web of Science - 11
1998 Clancy MJ, Pockney PG, 'Fitness to drive', JOURNAL OF ACCIDENT & EMERGENCY MEDICINE, 15 366-366 (1998)
Show 28 more journal articles

Conference (7 outputs)

Year Citation Altmetrics Link
2018 Petit J, Pockney P, Scott R, 'Methylation Specific Droplet Digital PCR Accurately Quantifies BCAT1 Allele in Colorectal Cancer Patients', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Co-authors Rodney Scott
2018 Gould T, Jamaluddin MFB, Pockney P, Dun M, 'Quantitative Proteomics for the Early Detection of Colorectal Cancer', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Co-authors Muhammad Jamaluddin, Matt Dun
2016 Al Mazi JT, Verrills N, Smith N, Pockney P, Hondermarck H, Dun M, 'A COMPARISON BETWEEN DATA-DEPENDENT ANALYSIS AND HIGH-RESOLUTION ACCURATE MASS TARGETED PROTEOMICS APPROACHES FOR THE QUANTIFICATION OF PLASMA BIOMARKERS IN COLORECTAL CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2016)
Co-authors Hubert Hondermarck, Matt Dun
2015 Scott R, Dooley S, Lewis W, Meldrum C, Pockney P, Draganic B, et al., 'Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testing', ANNALS OF ONCOLOGY, Barcelona, SPAIN (2015) [E3]
DOI 10.1093/annonc/mdv233.270
Co-authors Stephen Smith, Rodney Scott
2014 Gillies D, Gani J, Foster R, Pockney P, Duggan A, 'FAST TRACK COLONOSCOPY FOR POSITIVE FAECAL OCCULT BLOOD TESTING ( plus FOBT) IN A PUBLIC HOSPITAL SETTING', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014)
Co-authors Jonathan Gani
2013 Grice DM, Bauer DC, Duesing K, Li D, Greenfield P, Nielsen S, et al., 'Human and microbial transcriptomics from lean and obese individuals with colorectal cancer: A comparison of Total and Poly A RNA sequencing from clinical samples.', CANCER RESEARCH, Washington, DC (2013) [E3]
DOI 10.1158/1538-7445.AM2013-LB-237
Co-authors Stephen Smith, Rodney Scott
2003 King AT, Pockney PG, Clancy MJ, Moore BA, Bailey IS, 'An Early Warning System reliably identifies high-risk surgical ward patients early in their clinical deterioration', BRITISH JOURNAL OF ANAESTHESIA, LONDON, ENGLAND (2003)
Citations Web of Science - 1
Show 4 more conferences
Edit

Grants and Funding

Summary

Number of grants 23
Total funding $1,954,484

Click on a grant title below to expand the full details for that specific grant.


20195 grants / $697,880

Testing the impact of an Interactive Health Communication Application on days alive out of hospital and quality of life following surgery for colorectal cancer$298,835

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Steve Smith, Laureate Professor Robert Sanson-Fisher, Conjoint Professor Jonathan Gani, Dr Jon Gani, Associate Professor Mariko Carey, Doctor Sancha Robinson, Sancha Robinson, Professor Andrew Searles, Conjoint Professor Andrew Searles, Doctor Peter Pockney, Doctor Christopher Oldmeadow, Mr Chris Oldmeadow, Conjoint Associate Professor Ross Kerridge
Scheme Partnership Projects
Role Investigator
Funding Start 2019
Funding Finish 2023
GNo G1800929
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

HMRI MRSP Infrastructure Funding Cancer Program 2019$275,294

Funding body: NSW Ministry of Health

Funding body NSW Ministry of Health
Project Team Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Associate Professor Nikki Verrills, Doctor Peter Pockney, Doctor Steve Smith, Doctor Liz Fradgley, Professor Amanda Baker, Doctor Jude Weidenhofer, Conjoint Professor Stephen Ackland
Scheme Medical Research Support Program (MRSP)
Role Investigator
Funding Start 2019
Funding Finish 2019
GNo G1900048
Type Of Funding C2220 - Aust StateTerritoryLocal - Other
Category 2220
UON Y

A Double-Blind Randomised Placebo-Controlled Trial Assessing the Effect of Peri-Operative Intravenous Lignocaine and Post-Operative Lignocaine Neurovascular Plane Infusion on Natural Killer Ce$60,000

Funding body: Colorectal Surgical Society of Australia and New Zealand Foundation Pty Ltd

Funding body Colorectal Surgical Society of Australia and New Zealand Foundation Pty Ltd
Project Team Doctor Peter Pockney, Doctor Steve Smith, Associate Professor Simon Keely, Conjoint Professor Jonathan Gani, Doctor Gang Liu
Scheme Research Grant
Role Lead
Funding Start 2019
Funding Finish 2019
GNo G1901026
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON Y

Hide and Seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch Syndrome$43,688

Funding body: Cancer Council NSW

Funding body Cancer Council NSW
Project Team Doctor Peter Pockney
Scheme Research Grant
Role Lead
Funding Start 2019
Funding Finish 2020
GNo G1801224
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON Y

Lignocaine infusion in Colerectal cancer Patient Immune Cells LICPIC Study$20,063

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Doctor Peter Pockney
Scheme Research Grant
Role Lead
Funding Start 2019
Funding Finish 2019
GNo G1900371
Type Of Funding C2220 - Aust StateTerritoryLocal - Other
Category 2220
UON Y

20188 grants / $773,528

HMRI MRSP Infrastructure Funding Cancer Program 2018$365,173

Funding body: NSW Ministry of Health

Funding body NSW Ministry of Health
Project Team Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Associate Professor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker
Scheme Medical Research Support Program (MRSP)
Role Investigator
Funding Start 2018
Funding Finish 2018
GNo G1800336
Type Of Funding C2220 - Aust StateTerritoryLocal - Other
Category 2220
UON Y

The role of microbial oxygen sensing in the development of anastomotic leaks$121,525

Funding body: Fisher & Paykel Healthcare Limited

Funding body Fisher & Paykel Healthcare Limited
Project Team Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith
Scheme Research Consultancy
Role Investigator
Funding Start 2018
Funding Finish 2019
GNo G1701624
Type Of Funding C3211 - International For profit
Category 3211
UON Y

Mary Sawyer Postgraduate Scholarship in Cancer Research$85,500

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Dr Georgia Carroll, Associate Professor Simon Keely, Doctor Peter Pockney, Professor Marjorie Walker, Doctor Steve Smith, Doctor Andrea Mathe
Scheme Postgraduate Research Scholarship
Role Investigator
Funding Start 2018
Funding Finish 2020
GNo G1800612
Type Of Funding C3120 - Aust Philanthropy
Category 3120
UON Y

Investigation of disease markers in asymptomatic patients with colorectal carcinoma or colonic adenomas$81,337

Funding body: Streck

Funding body Streck
Project Team Doctor Matt Dun, Doctor Peter Pockney, Laureate Professor Rodney Scott
Scheme Research Grant
Role Investigator
Funding Start 2018
Funding Finish 2019
GNo G1800707
Type Of Funding C3211 - International For profit
Category 3211
UON Y

Lignocaine Infusion in Colorectal Cancer Patient Immune Cells LICPIC Study$59,993

Funding body: Hunter New England Local Health District

Funding body Hunter New England Local Health District
Project Team Doctor Peter Pockney, Doctor Stephen Smith, Doctor Steve Smith
Scheme Research Funding
Role Lead
Funding Start 2018
Funding Finish 2019
GNo G1801298
Type Of Funding C2220 - Aust StateTerritoryLocal - Other
Category 2220
UON Y

Analysis of luminal bacteria at the site of colorectal anastomoses and their association with anastomotic leaks$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith, Associate Professor Ian Grainge, Doctor Andrea Mathe
Scheme Project Grant
Role Investigator
Funding Start 2018
Funding Finish 2018
GNo G1701630
Type Of Funding C3120 - Aust Philanthropy
Category 3120
UON Y

A novel minimally invasive assay to identify patients with bowel cancer$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Peter Pockney, Laureate Professor Rodney Scott
Scheme Project Grant
Role Lead
Funding Start 2018
Funding Finish 2018
GNo G1800199
Type Of Funding C3120 - Aust Philanthropy
Category 3120
UON Y

Proteo Genomics for Screening Bowel Cancer$20,000

Funding body: Hunter New England Local Health District

Funding body Hunter New England Local Health District
Project Team Doctor Peter Pockney, Laureate Professor Rodney Scott
Scheme Research Funding
Role Lead
Funding Start 2018
Funding Finish 2020
GNo G1801085
Type Of Funding C2220 - Aust StateTerritoryLocal - Other
Category 2220
UON Y

20173 grants / $201,000

Improving access to colonoscopy by targeted waitlist management$141,000

A grant to examine waitlists for colonoscopy in public hospitals in Newcastle to look for concordance or otherwise with National Guidelines in the indication for colonoscopy.  Using the data extracted, a pragmatic proposal for ensuring closer adherence to guidelines to ensure appropriate use of public resources will be devised

Funding body: Cancer Institute of NSW

Funding body Cancer Institute of NSW
Project Team

C/Professor Jon Gani, C A/Prof Tony Proietto, Dr R Foster, Ms D Gillies, Mrs J Lack

Scheme Innovations in Cancer Control Grants
Role Lead
Funding Start 2017
Funding Finish 2018
GNo
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON N

HCRA Infrastructure Funding$40,000

Funding body: Hunter Cancer Research Alliance (HCRA)

Funding body Hunter Cancer Research Alliance (HCRA)
Scheme ....
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding External
Category EXTE
UON N

The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer$20,000

Funding body: John Hunter Charitable Trust Grant

Funding body John Hunter Charitable Trust Grant
Scheme John Hunter Charitable Trust Grant
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding External
Category EXTE
UON N

20162 grants / $111,200

Improving Access to Colonoscopy for Diagnosis of Symptomatic Patients at High Risk of Colorectal Cancer (CRD) in HNE LHD$90,000

Funding body: Cancer Instititue NSW

Funding body Cancer Instititue NSW
Scheme Innovation Grant
Role Lead
Funding Start 2016
Funding Finish 2016
GNo
Type Of Funding External
Category EXTE
UON N

A Propective Observational Study of CRP Velocity in Suspected Acute Appendicitis$21,200

Funding body: John Hunter Charitable Trust Grant

Funding body John Hunter Charitable Trust Grant
Scheme John Hunter Charitable Trust Grant
Role Lead
Funding Start 2016
Funding Finish 2016
GNo
Type Of Funding External
Category EXTE
UON N

20133 grants / $120,876

Introduction of Streamlined Access Pathways for Potential Colorectal Cancer Cases in the Lower Hunter$50,000

Funding body: Cancer Institute NSW

Funding body Cancer Institute NSW
Scheme Evidence to Practice Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo
Type Of Funding External
Category EXTE
UON N

Providing tailored web-based information to support colorectal cancer patients in their preparation for and recovery from surgery: A feasibility study$48,656

Funding body: Cancer Institute NSW

Funding body Cancer Institute NSW
Project Team Laureate Professor Robert Sanson-Fisher, Doctor Steve Smith, Doctor Sancha Robinson, Ms Gill Batt, Conjoint Professor Frans Henskens, Conjoint Associate Professor Ross Kerridge, Doctor Christopher Oldmeadow, Doctor Peter Pockney, Doctor Christopher Hayes
Scheme Evidence to Practice Grant
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1300868
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

A Phase 3 Randomised, Double Blind, Placebo Controlled Pragmatic Trial to Assess the Efficacy of Tranexamic Acid in Reducing the Blood Loss in Patients with Per Rectal Bleeding$22,220

Funding body: John Hunter Charitable Trust Grant

Funding body John Hunter Charitable Trust Grant
Scheme John Hunter Charitable Trust Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo
Type Of Funding External
Category EXTE
UON N

20121 grants / $20,000

Standardisation of Operative Equipment and Techniques for Common Acute General Surgery Operations$20,000

Funding body: Hunter New England LHD, NSW Health

Funding body Hunter New England LHD, NSW Health
Scheme Innovation Support Scholarship
Role Lead
Funding Start 2012
Funding Finish 2012
GNo
Type Of Funding External
Category EXTE
UON N

20111 grants / $30,000

Donation to Support CNC GI Clinical Research Position$30,000

Funding body: Hunter New England LHD, NSW Health

Funding body Hunter New England LHD, NSW Health
Scheme Division of Surgery
Role Lead
Funding Start 2011
Funding Finish 2011
GNo
Type Of Funding External
Category EXTE
UON N
Edit

Research Supervision

Number of supervisions

Completed5
Current11

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2019 PhD To Investigate the Aetiopathology and Long Term Outcomes of Surgery for Congenital Penile Anomalies PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2019 Masters Somatic Symptom Disorder and Undifferentiated Abdominal Pain; Prevalence, Diagnostic Accuracy and Comorbidity M Philosophy(Surgical Science), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2018 PhD The Role of Microbial Oxygen Sensing in the Development of Anastomotic Leaks PhD (Human Physiology), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2018 PhD The Introduction of an Emergency Laparotomy Audit in Australia PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2018 PhD Proteomic Analysis of Blood Based Biomarkers for the Early Detection of Colorectal Heoplasia PhD (Medical Biochemistry), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2018 PhD The Functional Effects of CD36 Polymorphisms in Colorectal Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2018 Masters ProNGF as a Urinary Biomarker for Prostate Cancer? M Philosophy(Surgical Science), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2018 PhD Microbiome of Surgical Site PhD (Anatomy), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2017 PhD Circulating Tumour DNA as a Novel Biomarker for Colorectal Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2017 PhD The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2017 PhD Nerve Dependence in Human Cancers PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2018 Masters Morbidity and Mortality of Colonoscopies in the Hunter New England Region
Masters degree in Surgical Sciences by distance learning, final year consists of a supervised research program leading through project design, interim reports and progress poster presentation to a final thesis submitted for assessment
Surgery, University of Edinburgh Principal Supervisor
2016 Masters A Potential Modifier Gene in Familial Adenosis Polyposis
This was a project that examined the genes of patients with FAP looking for evidence of modifier genes that affect the age of onset of polyposis and of developing cancer in patients with FAP.
Genetics, University of Edinburgh Co-Supervisor
2014 Masters Haemorhoid Goligher grade versus symptom severity
This was a pilot study of the correlation of patient reported symptoms compared to surgeon assessed clinical severity.
Surgery, The University of Sydney Principal Supervisor
2014 Honours Development of a Novel CO2 Insulflation Device for Laparotomy
This was an honours student project that developed a device that provided a constant infusion of CO2 to the wound edge in an animal model of a laparotomy wound, with the long term aim of developing a device that can reduce the incidence of aerobic infections in surgical wounds.
Surgery, NEWCASTLE UNIVERSITY Co-Supervisor
2013 Honours A randomised clinical trial to assess the efficacy of bolus vs infusion as a mode of delivery for local anaesthetic blocks following abdominal surgery
This was a randomised clinical trial of two methods of delivery of local anaesthetic to manage post-operative pain in patients who underwent abdominal surgery. &nbsp;The trial showed a modest difference in favour of bolus delivery. &nbsp;The trial included 120 patients. It has been presented at the Royal Australasian College of Surgeons Annual Scientific Meeting in 2015
Surgery, NEWCASTLE UNIVERSITY Co-Supervisor
Edit

Dr Peter Pockney

Position

Senior Lecturer
School of Medicine and Public Health
Faculty of Health and Medicine

Focus area

Medicine

Contact Details

Email peter.pockney@newcastle.edu.au
Phone (02) 4985 5527
Fax (02) 4921 4274

Office

Building .
Location John Hunter Hospital, Newcastle

,
Edit